NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/07/2025
Back to search
Official data from USPTO
MY LEO PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/07/2025
Trademark type
Combined
Nice classes
5, 38, 42, 44
Filing date
06/29/2021
Registration date
10/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2022
Last transaction
03/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DK
Examiner
O'BRIEN, JENNIFER
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a tripartite swoosh design above the words "MY LEO PHARMA".
Holders and representatives
Holders
LEO Pharma A/S
Representatives
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Technical classification
Nice Classes
Class 5Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and for treatment of the skin
Class 38
Providing online forums for information and communication about skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin
Class 42
Scientific and medical research in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; research in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; pharmaceutical research and development services in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; scientific research for medical purposes in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of medical researchproduct development and scientific research in relation to skin diseases and treatment of the skin; pharmaceutical teststesting of pharmaceuticals in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin
Class 44
Medical services in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; medicalhealth and pharmaceutical consultation services in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin; medical testsmedical testing for diagnostic or treatment purposes in the field of skin diseasesatopic dermatitisautoimmune and inflammatory diseases and in relation to treatment of the skin
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/06/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/10/2023
FIMP
FINAL DISPOSITION PROCESSED
02/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/18/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/02/2022
PUBO
PUBLISHED FOR OPPOSITION
08/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
08/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/13/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/16/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/16/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/16/2022
RFNT
REFUSAL PROCESSED BY IB
05/24/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/21/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/05/2022
RFRR
REFUSAL PROCESSED BY MPU
05/05/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/26/2022
CNRT
NON-FINAL ACTION WRITTEN
03/25/2022
DOCK
ASSIGNED TO EXAMINER
03/21/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/31/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/26/2021
Continuous trademark protection
Get notified about every new filing that threatens MY LEO PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.